Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease.

BACKGROUND Periodic, routine Papanicolaou smears of cells from the vagina are commonly examined in women who have undergone a hysterectomy for benign gynecologic disease. The benefits of this method of screening are not known. METHODS We analyzed Papanicolaou smears obtained from the vaginal apex (cuff) in 6265 women at Charity Hospital in New Orleans between January 1, 1992, and December 31, 1994. Of the 10,595 vaginal smears, an estimated 9610 were obtained during follow-up examinations of 5682 women who had undergone hysterectomy for benign gynecologic disease. RESULTS Among these 9610 vaginal smears, 104, from 79 women, were abnormal. The abnormal smears were categorized according to the findings, as follows: atypical squamous cells of undetermined significance, 52 (0.5 percent of all smears); low-grade squamous intraepithelial lesion, 44 (0.5 percent); high-grade squamous intraepithelial lesion, 6 (0.1 percent); and squamous-cell carcinoma, 2 (0.02 percent). In five women, biopsies revealed vaginal intraepithelial neoplasia type I or II; there were no biopsy-proved cases of vaginal cancer. The probability of an abnormal Papanicolaou smear in this group of women was 1.1 percent, and the positive predictive value of the Papanicolaou test for detecting vaginal cancer was 0 percent (95 percent confidence interval, 0 to 33 percent). CONCLUSIONS The prevalence of abnormal findings on cytopathological examination of vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease is extremely low.

[1]  D. Simel,et al.  Cytologic screening after hysterectomy for benign disease. , 1995, American journal of obstetrics and gynecology.

[2]  M. Handley,et al.  Cervicovaginal screening in women with HIV infection: a need for increased vigilance? , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  J. Paavonen,et al.  Natural history of vaginal intraepithelial neoplasia , 1991, Cancer.

[4]  L. Brinton,et al.  Case-control study of in situ and invasive carcinoma of the vagina. , 1990, Gynecologic oncology.

[5]  D. C. Chambers,et al.  The need for Pap tests after hysterectomy for benign disease. Results of a study of black patients. , 1987, Postgraduate medicine.

[6]  C. Hayes,et al.  Invasive Squamous Cell Carcinoma of the Vagina: A 14‐Year Study , 1987, Obstetrics and gynecology.

[7]  B. Sevin,et al.  Vaginal Cancer After Hysterectomy for Benign Disease: Value of Cytologic Screening , 1984, Obstetrics and gynecology.

[8]  R. Anderson,et al.  Squamous cell carcinoma of the vagina following hysterectomy. , 1981, American journal of obstetrics and gynecology.

[9]  J. A. Oliver Severe dysplasia and carcinoma in situ of the vagina. , 1979, American journal of obstetrics and gynecology.

[10]  A M Foltz,et al.  The annual Pap test: a dubious policy success. , 1978, The Milbank Memorial Fund quarterly. Health and society.

[11]  F. Lundin,et al.  Cervical cancer control. A study of morbidity and mortality trends over a twenty‐one‐year period , 1976 .

[12]  J. Merrill,et al.  Cancer and dysplasia of the post-hysterectomy vaginal cuff. , 1976, Gynecologic oncology.

[13]  Morley Gw,et al.  Carcinoma in situ of the vagina. A study and review. , 1975 .

[14]  D. Cramer,et al.  Incidence and histopathology of malignancies of the female genital organs in the United States. , 1974, American journal of obstetrics and gynecology.

[15]  L. Kurland,et al.  Evaluation of the effectiveness of cytologic screening for cervical cancer. II. Survival parameters before and after inception of screening. , 1972, Mayo Clinic proceedings.

[16]  D. Decker,et al.  Carcinoma in situ of the vagina. , 1970, American journal of obstetrics and gynecology.

[17]  W. Christopherson,et al.  Control of cervix cancer in women of low income in a community , 1969, Cancer.

[18]  Green Gh,et al.  Vaginal carcinoma in situ following hysterectomy. , 1969 .

[19]  F. Rutledge Cancer of the vagina. , 1967, American journal of obstetrics and gynecology.

[20]  Diane Solomon,et al.  The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991. , 1993, Acta cytologica.